Cantor Fitzgerald analyst, William Tanner, reiterated his Neutral rating on shares of Novavax (NASDAQ: NVAX) on the belief that the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE